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Unlike other organs the nervous system is secluded from the rest of the organism by the
blood brain barrier (BBB) or blood nerve barrier (BNB) preventing passive influx of fluids
from the circulation. Similarly, leukocyte entry to the nervous system is tightly controlled.
Breakdown of these barriers and cellular inflammation are hallmarks of inflammatory as
well as ischemic neurological diseases and thus represent potential therapeutic targets.
The spatiotemporal relationship between BBB/BNB disruption and leukocyte infiltration has
been a matter of debate. We here review contrast-enhanced magnetic resonance imaging
(MRI) as a non-invasive tool to depict barrier dysfunction and its relation to macrophage infil-
tration in the central and peripheral nervous system under pathological conditions. Novel
experimental contrast agents like Gadofluorine M (Gf) allow more sensitive assessment
of BBB dysfunction than conventional Gadolinium (Gd)-DTPA enhanced MRI. In addition,
Gf facilitates visualization of functional and transient alterations of the BBB remote from
lesions. Cellular contrast agents such as superparamagnetic iron oxide particles (SPIO)
and perfluorocarbons enable assessment of leukocyte (mainly macrophage) infiltration by
MR technology. Combined use of these MR contrast agents disclosed that leukocytes can
enter the nervous system independent from a disturbance of the BBB, and vice versa,
a dysfunctional BBB/BNB by itself is not sufficient to attract inflammatory cells from the
circulation. We will illustrate these basic imaging findings in animal models of multiple
sclerosis, cerebral ischemia, and traumatic nerve injury and review corresponding findings
in patients.
Keywords: contrast-enhanced MRI, gadolinium-DTPA, gadofluorine, iron oxide nanoparticles, blood brain barrier,
neuroinflammation
INTRODUCTION
An important feature of the brain that sets it apart from other
organs is the presence of the blood brain barrier (BBB), a selec-
tive barrier to the central nervous system (CNS) that impedes
the influx of most compounds from blood to brain. The con-
cept of a BBB dates to the late nineteenth century when Ehrlich
(1885) observed that water-soluble dyes injected into the circula-
tion leak into all organs of rodents except for the brain. Since then
the image of the BBB changed from a static physical wall into a
dynamic interface between the blood and the CNS that controls
the supply of nutrients while simultaneously shielding it off from
potentially harmful substances. The central anatomical substrate
of the BBB is the cerebral endothelium which is characterized
by the presence of tight cell–cell junctions (Kniesel and Wolburg,
2000), lack of fenestrations (Fenstermacher et al., 1988), and low
pinocytotic activity (Sedlakova et al., 1999). These features restrict
paracellular diffusion of water-soluble substances from blood to
brain (Hawkins and Davis, 2005). In addition, the BBB is com-
posed of large numbers of pericytes that are embedded into the
vascular basement membrane and a layer of astrocytic end-feet
ensheathing the vessels (Ballabh et al., 2004). They, together with
the endothelial cells, form the so-called neurovascular unit which
ensures homeostasis of the CNS microenvironment. Similarly, in
the peripheral nervous system (PNS) nerve fibers are protected
from the circulation by a blood nerve barrier (BNB).
Impairment of the BBB or the BNB is a critical step in the
development and progression of neurological conditions such
as ischemic stroke (Latour et al., 2004) and multiple sclerosis
(MS; Minagar and Alexander, 2003), but also traumatic brain
(Schwaninger et al., 1999) or nerve injury (Seitz et al., 1989).
Inflammation is another common hallmark of these disorders.
It involves a complex cascade of events in which both, the activa-
tion of resident glial cells as well as the infiltration of bone-marrow
derived leukocytes play an important role and might impact dis-
ease progression. While in ischemic stroke and trauma inflam-
mation occurs as a response to brain or nerve tissue damage,
in autoimmune disorders such as MS, inflammation initiates the
disease. Hence, in both cases, preservation of BBB/BNB integrity
and the prevention of inflammatory responses constitute promis-
ing therapeutic targets. However, application of barrier stabilizing
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anti-edematous or anti-inflammatory treatments requires precise
knowledge of the timing and location of BBB/BNB disturbances
as well as cellular inflammation.
Conventional magnetic resonance imaging (MRI) that is rou-
tinely used to assess CNS and PNS pathologies gives only a gross
estimate of tissue damage. Moreover, signal changes are non-
specific and do not allow discrimination of areas with edema
formation, inflammation, or glial scarring. Recently, novel MR
contrast agents helped to gain deeper insights into the plurifor-
mity of neuroinflammation. The present review focuses on the
visualization of BBB and BNB disturbances by Gadolinium (Gd)-
DTPA and Gadofluorine (Gf) enhanced MRI and depiction of
cellular inflammation by iron particle and perfluorocarbon (PFC)-
based cellular MRI. By combining these imaging techniques it
became apparent that the spatiotemporal relationship between
breakdown of the BBB/BNB and leukocyte infiltration is more
complex than previously anticipated. To illustrate these issues we
will use three paradigmatic disorders of the nervous system as
models: ischemic stroke, MS with its animal model, experimen-
tal autoimmune encephalomyelitis (EAE), and finally traumatic
peripheral nerve injury.
MR IMAGING OF BBB AND BNB DISTURBANCES
CONVENTIONAL GD-DTPA ENHANCED MRI
Gadolinium-based MR contrast agents are licensed for a broad
range of clinical applications. In the nervous system Gd-DTPA is
routinely applied to identify areas with BBB/BNB dysfunction.
Upon systemic application it extravasates out of the intravas-
cular compartment at sites with a leaky BBB and accumulates
locally leading to a substantial T1-shortening effect within that
region. Importantly, signal changes rapidly decline due to a rever-
sal of the diffusion gradient upon clearance of Gd-DTPA from the
circulation.
Multiple sclerosis
In MS, a chronic inflammatory demyelinating disease of the CNS,
Gd-DTPA enhanced MRI is the current gold standard for the
evaluation of acute disease activity. However, whereas Gd-DTPA
enhancement reliably predicts the occurrence of relapses it does
not correlate with cumulative impairment and disability (Fil-
ippi et al., 2011). Moreover, as triple-dose Gd-DTPA significantly
increased the harvest of enhancing lesions (Silver et al., 2001) it
became obvious that conventional Gd-DTPA enhanced MRI only
captures a small portion of lesions with a dysfunctional BBB.
Ischemic stroke
Ischemic stroke regularly leads to disruption of the BBB which
already starts a few hours after the onset of ischemia and lasts for
several weeks (Strbian et al., 2008; Brouns and De Deyn, 2009).
Interestingly, early parenchymal Gd-DTPA enhancement appears
to be a predictor of hemorrhagic transformation in experimental
stroke (Knight et al., 1998). Nonetheless, changes of the infusion
protocol in rodent studies revealed that subtle changes in BBB per-
meability are missed by standard dose Gd-DTPA enhanced MRI.
Among other reasons this might be due to the greatly lowered
blood flow in the affected region that leads to suboptimal delivery
of the contrast agent (Nagaraja et al., 2007). Thus, especially in the
acute ischemic phase BBB disturbances might escape detection by
conventional Gd-DTPA enhanced MRI (Merten et al., 1999).
Nerve trauma
As in the brain, nerve injury in the PNS is frequently accompanied
by breakdown of the BNB. Nerves undergoing Wallerian degen-
eration (WD) after transection or crush injury characteristically
show a prolongation of the T2 relaxation time at the lesion site and
distally in conventional MRI (Does and Snyder, 1996). However,
despite extravasation of albumin and Evans blue in experimental
studies as clear evidence for BNB opening Gd-DTPA enhance-
ment is not consistently detected in injured nerves (Cudlip et al.,
2002; Lacour-Petit et al., 2003). Hence, it cannot be considered as
a reliable measure for BNB integrity or dysfunction.
GADOFLUORINE ENHANCED MRI: A NOVEL TOOL FOR EXPERIMENTAL
RESEARCH
Important proof-of-principle studies with Gf M, a novel experi-
mental MR contrast agent developed by the former Schering AG
(Berlin, Germany) revealed that BBB/BNB disturbances are more
widespread than previously anticipated and can involve brain
areas remote from focal lesions. Gf represents a highly fluorinated
Gd-compound originally developed for MR lymphography and
imaging of atherosclerotic plaques (Meding et al., 2007). We and
others directly compared Gd-DTPA and Gf enhancing lesions in
EAE, stroke, and nerve injury and found that Gf detects BBB and
BNB disturbances with much higher sensitivity than Gd-DTPA.
In these experimental settings Gf enhancement exactly matched
the leakage of systemically applied Evans blue, a common marker
for albumin extravasation across the BBB. In comparison to Gd-
DTPA, Gf has unique molecular binding properties that might
explain the different elimination kinetics and its higher sensitivity.
Upon intravenous injection Gf is largely bound to serum albumin.
It passively diffuses into the nervous system at sites of a leaky BBB
or BNB, but, unlike Gd-DTPA gets trapped by local interactions.
Thus, Gf persists in lesions long after clearance from the circula-
tion which usually occurs within 24 h after application. Although
the binding partners at the molecular level in the CNS and PNS
have not yet been elucidated, in vitro studies suggested that Gf
avidly binds to components of the extracellular matrix (Meding
et al., 2007).
Experimental autoimmune encephalomyelitis, the animal model
of MS
Experimental autoimmune encephalomyelitis is the most widely
used animal model for MS. EAE lesions show lymphocyte and
macrophage infiltration, variable degrees of demyelination, and
leakage of the BBB. EAE lesions can be detected on T2-weighted
(w) MRI similar to MS lesions, and partly show Gd-DTPA
enhancement on T1-w MRI. When Gd-DTPA- and Gf enhancing
lesions were counted, the number of Gf positive EAE lesions by
far outnumbered Gd-DTPA positive lesions in individual EAE ani-
mals (Bendszus et al., 2008). Moreover, many Gf enhancing lesions
were not yet visible on parallel T2-w MRI, the standard sequence
to quantify lesion load in MS patients (Figure 1). Thereby, even
spinal cord (Figure 1) and optic nerve lesions (Figures 2A–D) that
often fail to be visualized despite unambiguous clinical involve-
ment could be depicted by Gf on a standard 1.5 T MR scanner.
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FIGURE 1 | Gf enhances detection of inflammatory lesions with a
dysfunctional BBB in EAE. A coronal T1-w image of the brain 24 h after
systemic application of Gf to a diseased rat displays bright enhancement in
the periventricular region (A). By contrast, corresponding coronal T2-w MRI,
the standard measure for overall disease burden in MS, shows only a tiny
periventricular lesion [arrow in (B)]. Sagittal T1-w MRI reveals, amongst
other contrast enhancing lesions, a large Gf positive lesion in the dorsal
column of the cervical spinal cord [arrow in (C)] that is verified on a
macroscopic preparation of the entire medulla (D). Foci with Gf deposition
appear pink due to the coupling with a carbocyanine dye. Intraindividual
comparison of Gf and Gd-DTPA enhancement on coronal slices shows
extensive Gf enhancement in the left posterolateral cervical spinal cord (F)
while Gd-DTPA uptake is far more limited (E). On corresponding T2-w MRI
the lesion is indiscernible (G). Adapted from Bendszus et al. (2008).
In a subgroup of animals spinal cord specimens were analyzed
for Gf uptake and parenchymal inflammation. Foci of Gf depo-
sition could be detected macroscopically due to the coupling
with a carbocyanine dye. Importantly, all tissue specimens devoid
of inflammation were Gf negative, while Gf enhancing lesions
always exhibited microglial activation or macrophage infiltration.
However, a considerable number of lesions with low-grade inflam-
mation failed to show Gf uptake. By contrast, severe inflammation
was always accompanied by Gf accumulation. A possible explana-
tion for this observation, besides sensitivity issues, could be that
foci with mild microglia activation/macrophage infiltration, but
without BBB leakage, represent initial stages of lesion development
whereas severe inflammation secondarily evokes BBB opening.
The enhanced sensitivity of Gf for EAE lesion detection was
confirmed independently at 7 T high field MRI (Wuerfel et al.,
2010). Among a total of 61 contrast enhancing lesions 26 were
exclusively visible after Gf administration (nine of them in the
optic nerve). The remarkable improvement in lesion detection
was accompanied by early Gf uptake in the circumventricular
organs (CVO) of diseased animals. The CVO are particular areas
of the brain with an incomplete endothelial BBB that participate
in immune cell recruitment to the CNS (Schulz and Engelhardt,
2005). Interestingly, Gf mean intensity ratios in the subfornic-
ular organ and the area postrema significantly correlated with
disease severity and onset of symptoms suggesting that early Gf
enhancement in the CVO might be a predictor of the clinical EAE
course.
Ischemic stroke
Similarly, in cerebral ischemia Gf is much more sensitive than Gd-
DTPA enhanced MRI. Brain photothrombosis (PT) is a simple
model of focal cerebral ischemia that uses local intravascular photo
peroxidation to generate highly circumscribed ischemic cortical
lesions with almost immediate breakdown of the BBB. Accord-
ingly, PT lesions exhibit an early and strong Gd-DTPA and Gf
uptake on T1-w MRI. However, within the first 12 h after the onset
of ischemia Gf enhancement, in addition, gradually extended to
the entire ipsilateral hemisphere (Stoll et al., 2009b) that under-
goes functional alterations, but lacks neuronal damage (Witte and
Stoll, 1997). These Gf enhancing areas remote from the lesions
did not show Gd-DTPA enhancement. Importantly, the timing of
Evans blue extravasation on macroscopic brain slices and histo-
logical sections exactly matched the evolution of Gf enhancement
on in vivo MRI (Stoll et al., 2009b; Figure 3). Several conclusions
can be drawn from these observations: (i) Leakage of the BBB is
not restricted to structural brain lesions, but also occurs in intact
brain areas. Thus, functional states without structural damage can
lead to intermittent and fully reversible opening of the BBB. Eluci-
dation of the underlying mechanisms of these transient BBB dis-
turbances might help to develop physiological means to open the
BBB for drug delivery. (ii) Lesion-associated BBB disturbances are
more abundant in autoimmune disorders of the CNS and ischemic
stroke than previously appreciated. Thus, further MR contrast
development is warranted since the capabilities of routinely
used Gd-DTPA are limited. Fortunately, derivates of Gf are now
commercially available for research purposes in animal models.
Nerve trauma
Nerve degeneration after traumatic injury is accompanied by
breakdown of the BNB (Seitz et al., 1989; Bouldin et al., 1991),
but, surprisingly, injured nerves do not regularly show Gd-DTPA
enhancement (reviewed in Stoll et al., 2009a). Contrastingly, the
process of nerve degeneration and subsequent recovery can be
assessed by Gf enhanced MRI (Bendszus et al., 2005b) due to the
fact that the BNB is disturbed during the degeneration process,
but sealed again upon arrival of regenerating nerve sprouts from
the proximal stump. Forty-eight hours after crush injury of sci-
atic nerves in male Wistar rats Gf accumulated within the entire
nerve and its lower leg branches undergoing WD and persisted
until successful regeneration (Figures 4A,B). Likewise, intense
nerve enhancement was present after chronic constriction injury
leading to less severe axonal damage. Within several weeks Gf
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FIGURE 2 | Gf improves EAE lesion detection in optic nerves (ON)
belonging to the CNS (A-D). Twenty-four hours after systemic administration
of Gf coronal T1-w MRI shows bilateral disturbance of the blood-optic nerve
barrier [arrows in (A)]. The macroscopic preparation of the left ON (B)
confirms extravasation of labeled Gf. Thereafter the ON was embedded in
paraffin and longitudinal sections were stained for macrophages (ED-1) (C)
and myelin (Luxol fast blue) (D). Note that the Gf enhancing ON is heavily
infiltrated by ED-1 positive macrophages (C) and almost completely
demyelinated [lack of deep blue staining in (D)]. (E,F) depict the spatial
discrepancy between cellular inflammation and BBB dysfunction in EAE.
Coronal CISS (constructive interference steady state) MRI of a severely
affected rat 24 h after SPIO application shows strong signal loss in both optic
nerves [arrows in (E)]. By contrast, the same animal lacks retrobulbar Gf
enhancement on corresponding T1-w MRI 24 h after Gf administration (F)
indicating that macrophages infiltrated the ON without concomitant
disturbance of the blood-optic nerve barrier. Since acute macrophage
infiltration as shown in (E) does not immediately cause leakage of the BBB
allowing access of Gf (F) we speculate that BBB dysfunction is a secondary
and delayed event dependent on previous macrophage infiltration. Adapted
from Bendszus et al. (2008) (A) and Ladewig et al. (2009) (E,F).
uptake gradually declined from proximal to distal parts of the
injured nerve in parallel to regrowth of nerve fibers. Thus, Gf
enhanced MRI holds promise to bridge the current diagnostic gap
between nerve injury and completed regeneration. Moreover, since
non-regenerating, permanently transected nerves exhibit persis-
tent Gf enhancement (Bendszus et al., 2005b), Gf enhanced MRI
might help to discern the need for surgical nerve release or graft-
ing if spontaneous regeneration fails. Consequently, Liao et al.
(2012) successfully applied Gf enhanced MRI to monitor nerve
regeneration after implantation of chitosan nerve conduits with
mesenchymal stem cells in a rat model of neurotmesis.
CELLULAR MRI
SPIO/USPIO ENHANCED MRI
Gadolinium-DTPA and Gf enhanced MRI are crude indicators
of BBB or BNB disturbances, but they do not specifically visu-
alize cellular immune responses. Inflammation, however, plays a
major role in disorders of the nervous system. While under healthy
conditions immune cell access to the nervous system is restricted,
leukocytes readily cross the BBB or BNB in the context of patho-
physiological processes and enter the neural tissue guided by cell
adhesion molecules and chemokines (Man et al., 2007).
There is an ongoing controversy whether immune cell invasion
is linked to BBB disruption or occurs independently (see below).
A prerequisite for solving this issue are imaging tools that allow
monitoring of cell migration in vivo. From a clinical perspective,
tracking of inflammatory cells could moreover help to identify
active phases of CNS and PNS inflammation and to monitor the
efficacy of therapeutic interventions. Thus, it is not surprising
that cellular neuroimaging has become a field of intense research
effort. The preferentially applied contrast agents for cellular MRI
are iron oxide nanoparticles and lately, PFC (see Perfluorocarbon
Enhanced 19F MRI). Depending on their hydrodynamic parti-
cle size iron nanoparticles are classified into superparamagnetic
iron oxide particles (SPIO; 50–200 nm diameter) and their ultra
and very small variants (USPIO;∼35 nm diameter;VSOP< 10 nm
diameter). They all possess relatively large negative magnetic sus-
ceptibilities, featuring a more extensive shortening of T1 and T2
relaxation times than Gd-DTPA. Hence, their sensitivity is much
higher than that of Gd compounds. The easiest and safest method
of iron labeling is spontaneous uptake by blood-borne cells after
systemic contrast agent application (Bulte, 2009). If thereafter
labeled cells are attracted to a target organ they can be visualized
by MRI. Importantly, the property to phagocytose and to migrate
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FIGURE 3 | Visualization of transient BBB opening remote from a
photothrombotic lesion by Evans Blue extravasation (A,B), Gd-DTPA
(C,E) and Gf enhanced MRI (D,F). Rats received Evans Blue i. v.
immediately after PT induction or with a delay of 48 h (for 72 h analysis) and
were sacrificed at given time points. Total brain preparations (A) and coronal
brain sections (B) of the animals show that Evans Blue extravasation starts
at the lesion site, but extends to the remote ipsilateral cortex and the corpus
callosum within the first day. Coronal brain slices at the level of the lesion
are always shown on top, the other six in the row represent subsequent
1 mm slices located frontally to the lesion (B). At day 3 breakdown of the
BBB indicated by Evans blue extravasation is restricted to the PT lesion. (E)
shows Gd-DTPA enhancement of the photothrombotic lesion within the
first 24 h. Note that, in contrast, Gf enhancement occurs within in the
lesion, but also affects the ipsilateral cortex and the corpus callosum spared
by Gd-DTPA (F). Moreover, T1-w MR images anterior to the PT lesion
exhibit no Gd-DTPA (C), but strong Gf enhancement (D) according to Evans
blue extravasation shown in (A,B). Reproduced from Stoll et al. (2009b).
to sites of inflammation turns macrophages into ideal targets for
cellular MRI. Apart from macrophage phagocytosis SPIO/USPIO
are cleared from the circulation by cells of the reticuloendothelial
system (RES) in liver and spleen. The extent of cellular labeling
in relation to clearance by the RES depends on iron oxide parti-
cle size and the net charge of the polymer coating (Hoehn et al.,
FIGURE 4 |Visualization of breakdown of the blood nerve barrier (BNB)
(A,B) and inflammation in experimental nerve crush (C–F). Coronal
images depict the pelvis and both thighs of a rat lying in prone position with
both legs positioned in a round surface coil (CISS sequence; slice thickness
1 mm). Note that Gf accumulates in the degenerating distal stump on T1-w
MRI [arrow in (A)] and binds to peripheral nerve structures as revealed by
fluorescence of carbocyanine-labeled Gf (B). Gf enhancement ceases not
until successful regeneration (not shown). By contrast to breakdown of the
BNB, macrophage infiltration is restricted to the early phase of Wallerian
degeneration. Five days after sciatic nerve crush focal signal loss is present
at the lesion site and distally due to the invasion of SPIO-labeled
macrophages from the blood (C). The corresponding paraffin section
stained for iron confirms the infiltration of numerous iron-laden
macrophages in the degenerating nerve segment (D). At day 8,
macrophage infiltration is restricted again to the lesion site and ceases
thereafter (E). Correspondingly, distal nerve segments no longer show
iron-positive cells after application of SPIO as shown for day 10 in (F). The
BNB, however, is still leaky at that time (not shown) indicating that
macrophage infiltration occurs within a narrow time window and persistent
BNB disturbance does not per se induce cellular infiltration. Adapted from
Bendszus et al. (2005b); (A,B) and Bendszus and Stoll (2003) (C–F).
2007). Safety concerns for both, SPIO and USPIO compounds are
little. A recent meta-analysis of 37 phase I to III clinical trials with
ferumoxtran-10, an USPIO agent, revealed back pain, pruritus,
headache, and urticaria as the most frequent adverse events (Bernd
et al., 2009). They are usually mild and of short duration (Anzai
et al., 2003). Similarly, SPIO have been associated with low human
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toxicity. In numerous clinical trials they were shown to cause nei-
ther cardiovascular side effects nor clinically relevant laboratory
changes (Bluemke et al., 2003; Reimer and Balzer, 2003).
EAE and MS
Several proof-of-principle studies have demonstrated that USPIO
and SPIO enhanced MRI allow visualization of macrophage infil-
tration in EAE (Dousset et al., 1999; Rausch et al., 2003; Floris et al.,
2004). Brochet et al. (2006) showed that rats with USPIO positive
lesions at the first attack suffer from more severe clinical affection
and extensive axonal damage at the second EAE bout. This implies
that the extent of macrophage infiltration in early EAE may pre-
dict the ensuing disease course. Interestingly, in a follow-up study
by the same group severely affected rats with USPIO enhancement
at the onset of disease showed an imbalanced, proinflammatory
macrophage activation profile,both in CNS lesions and the periph-
eral blood (Mikita et al., 2011). Moreover, macrophage invasion
spread from the upper spinal cord and brainstem to the cere-
bellum and subcortical regions during disease progression. When
USPIO were injected in the recovery phase no signal abnormalities
were observed indicating that macrophage infiltration in EAE is a
timely restricted event that clearly depends on the disease stage.
In addition, iron-enhanced MRI was applied as a non-invasive
tool for preclinical treatment surveillance. Deloire et al. (2004)
demonstrated that macrophage recruitment to the EAE lesions
detected by USPIO enhanced MRI is not fully blocked under ther-
apy with natalizumab, a VLA4-antagonist that is in frequent use
in patients with relapsing-remitting MS. Moreover, the efficacy
of Fingolimod, an oral drug that was recently approved for MS
treatment, was successfully monitored by USPIO enhanced MRI
in EAE (Rausch et al., 2004).
In MS it is a common conception that the poor clinico-
radiological association may be explained in part by diffuse
inflammatory activity in the so-called normal appearing white
matter (NAWM) which is concealed behind an intact or repaired
BBB (Barkhof, 2002; Kutzelnigg et al., 2005). Indeed, microscopic
inflammation within the NAWM not amenable by conventional
MRI seems to contribute more strongly to disability than the T2
lesion load (Parry et al., 2002; Traboulsee et al., 2003). Thus, it
was not surprising that the application of iron-enhanced MRI
in EAE and the transfer of this technology to MS patients in
small trials have provided insights into CNS inflammation that
exceed conventional Gd-DTPA enhanced MRI. Vellinga et al.
(2008) detected 188 USPIO positive cerebral lesions in 14 patients
with active relapsing-remitting MS. Interestingly, the vast major-
ity of USPIO positive lesions (144/188) showed no concomitant
Gd-DTPA enhancement. Furthermore, none of the three differ-
ent types of USPIO enhancement (i) focal lesions (ii) “return
to isointensity” lesions and (iii) ring-enhancing lesions was par-
ticularly related to Gd-DTPA uptake (Vellinga et al., 2008). A
more recent clinical trial by the same group suggested USPIO
as a potential marker for diffuse inflammation in the NAWM of
relapsing-remitting and primary progressive MS patients (Vellinga
et al., 2009). T1 histogram and region-of-interest analysis in the
NAWM showed diffuse T1-shortening after USPIO injection in 16
MS patients indicative of subtle inflammatory activity, but not in
gender- and age-matched healthy controls.
Ischemic stroke
It has long been established that cerebral ischemia induces a
profound inflammatory response involving neutrophils, T-cells,
and macrophages (Stoll et al., 1998). In the simple model of
photothrombotic infarction (see above), entry of phagocytic
hematogenous macrophages is delayed by several days and peaks
around days 6–9 after lesion induction (Schroeter et al., 1997).
Accordingly, SPIO-induced signal alterations did not occur until
day 5 despite persistent breakdown of the BBB in PT lesions.
However, at day 6 a hypointense rim appears followed by signal
loss in more central areas reflecting the influx of hematogenous
macrophages as confirmed by histological analysis (Kleinschnitz
et al., 2005). Macrophage inflammation could also be visualized by
SPIO/USPIO enhanced MRI after transient or permanent middle
cerebral artery occlusion (MCAO), but results are more hetero-
geneous and conflicting. Some groups found contrast-induced
signal loss in the lesion boundary 24 h after permanent MCAO
(Rausch et al., 2001). In a transient MCAO model, Denes et al.
(2007) did not find USPIO-related signal loss within the first
3 days after stroke induction. Moreover, neither focal signal inten-
sity changes nor iron-positive macrophages were detected in the
ischemic hemisphere of Wistar rats when USPIO were applied at a
subacute stage 6 days after MCAO (Farr et al., 2011). By contrast,
Kim et al. (2008) found areas of signal loss in SPIO enhanced MRI
3 days after reperfusion that corresponded to the accumulation of
iron-laden macrophages. A possible explanation for these contra-
dictory results is that the labeling efficacy of monocytes by USPIO
in comparison to larger nanoparticles such as SPIO is rather low
(Oude Engberink et al., 2007). Moreover, the timing of the con-
trast agent application and the subsequent MRI appears to have
critical impact on the processes depicted by iron-enhanced MRI.
Hence, especially in the early infarct phase, focalized signal alter-
ations might rather be caused by trapping of the iron particles in
the vasculature than phagocyte infiltration (Desestret et al., 2009).
Several open-label pilot trials with USPIO enhanced MRI were
conducted in patients with ischemic stroke. Saleh et al. (2004)
applied USPIO in a series of 10 patients 5–6 days after stroke onset.
MRI scans were performed 24 and 48 h after USPIO infusion.
As principal finding two distinct USPIO-related signal changes
were observed: blood pool effects that appeared as signal loss on
T2/T2∗-w images and decreased from the first to the second scan
as well as parenchymal contrast enhancement on T1-w images
that increased over time and was attributed to macrophage infil-
tration. When applied early (24–36 h after stroke) in a subsequent
study, USPIO enhancement was spatially heterogeneous and only
present in a minority of patients (Saleh et al., 2007). Nighoghossian
et al. (2007) recruited patients with anterior circulation stroke and
administered USPIO 6 days after admission. Three days later, 9 of
10 patients showed USPIO enhancement in the brain parenchyma.
Interestingly, whilst most patients featured mild Gd-DTPA uptake,
the patient with the most severe BBB breakdown did not exhibit
USPIO enhancement.
Nerve trauma
Traumatic injury to peripheral nerves similarly induces a pro-
found inflammatory response with macrophage infiltration (Stoll
et al., 1989) that leads to rapid removal of myelin debris and a
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growth-promoting cellular and molecular milieu. Thus, WD is
the prototype of a tissue protective M2 type macrophage response
(Ydens et al., 2012). SPIO enhanced MRI helped to define the
kinetics of macrophage entry into the degenerating nerve seg-
ments which starts around day 1 or 2 at the lesion site and
extends to the entire distal stump within the first 2 weeks after
injury (Bendszus and Stoll, 2003; Figures 4C,D). Accumula-
tion of SPIO-laden macrophages was visible as focal signal loss
on T2-w MRI. When SPIO particles were applied 10 days after
crush or later degenerating nerves did no longer exhibit signal
loss (Figure 4E) despite the presence of numerous myelin-laden
macrophages in the endoneurium. There are two possible explana-
tions for this finding: (i) SPIO-based MRI depicts active migration
of macrophages from the circulation into nerves, and lack of signal
at later stages of WD indicates no further macrophage recruit-
ment (Figure 4F). (ii) Alternatively, myelin-loaded macrophages
no longer phagocytose iron particles within the injured nerves. We
favor the first possibility since the dynamics of macrophage infil-
tration shown by SPIO enhanced MRI closely resembles the local
expression pattern of macrophage attracting chemokines, which
ceases around day 10 (Toews et al., 1998; Tofaris et al., 2002).
Moreover, our data suggests that simple leakage of SPIO particles
through a defective BNB does not significantly change the intrinsic
nerve MR signal, at least in the PNS. These results were recently
confirmed in a rodent model of radicular pain. Seven days after
transient dorsal root compression T2∗–w MRI showed significant
iron-induced signal alterations in the nerve roots of the injured,
but not of the sham-operated group after systemic application of
SPIO (Thorek et al., 2011).
PERFLUOROCARBON ENHANCED 19F MRI
Despite its excellent sensitivity iron particle based cellular MRI
has several shortcomings. These include false-positive results
caused by hemorrhages, blood pool effects and, in some instances,
(depending on the half-time of the compound) passive diffusion
via a defective BBB or BNB. Additionally, the large 1H back-
ground signal from mobile water renders unambiguous detection
of labeled cells in vivo difficult especially if their biodistribution
is unclear. Recently, fluorine (19F) MRI has emerged as an alter-
native approach for cellular imaging (Stoll et al., 2012; Temme
et al., 2012). 19F markers exhibit favorable MR imaging charac-
teristics, such as a magnetic sensitivity close to the proton nucleus
and high natural abundance. Moreover, because of the lack of
endogenous 19F-containing molecules in the body signals origi-
nating from injected 19F compounds are specific. Another virtue
of 19F MRI is that it can be performed in a quantitative manner.
Ideal fluorine tracers should provide a high payload of 19F nuclei.
PFC compounds fulfill this requirement and thus were established
as tracers for 19F MRI in recent years. In animal studies PFC
agents were generally well-tolerated (Ebner et al., 2010). Several
PFC compounds have also been elaborately studied as artificial
blood substitutes (Spahn et al., 2002). In one of these clinical tri-
als cerebral hemorrhages occurred after cardiopulmonary bypass
surgery but thorough analysis of the safety data revealed that the
study conduct, and not the PFC emulsion itself was responsible for
the adverse events (Riess, 2006). Moreover, extensive analysis dis-
closed no perturbation of hemostasis or blood viscosity after i. v.
treatment with PFC that could be related to the observed bleeding
tendency (Riess, 2006).
Flogel et al. (2008) were the first to show that systemically
injected 19F emulsions are efficiently phagocytosed by circulat-
ing monocytic cells. Moreover, in mice with myocardial infarction
they were able to monitor a time-dependent PFC accumulation
in the infarct area. It is well known that myocardial ischemia
induces an inflammatory response dominated by cells of the
monocyte/macrophage system. Consistently, rhodamine-labeled
PFC allowed the identification of 19F-positive cells within the
infarction as macrophages. Subsequently, in vivo 19F MRI was suc-
cessfully applied to monitor immune cell responses in mice with
LPS-induced pneumonia (Ebner et al., 2010), abscess formation
(Hertlein et al., 2011), and in models of acute allograft rejection
(Flogel et al., 2011; Hitchens et al., 2011). However, studies using
19F MRI in the nervous system are sparse. Probably due to the
low accumulation of PFC compounds in inflammatory lesions
of the CNS/PNS compared to other organ systems sensitivity is
a major concern (Stoll et al., 2012). Lately, we established 19F
MRI to depict macrophage infiltration in a rat model of focal
inflammatory peripheral nerve injury (Weise et al., 2011). Focal
injection of lysolecithin chemically dissolves myelin sheaths and,
thereby, elicits a strong inflammatory response within the demyeli-
nated nerve segment (Griffin et al., 1990). In vivo MRI 5 days after
sciatic nerve damage revealed massive migration of 19F labeled
cells to the injured nerve section. Intraneural application of saline
to the contralateral nerve provoked a slight inflammatory reac-
tion restricted to the perineurium which could also be visualized
by 19F MRI. However, quantification of the signal strength by ex
vivo 19F spectroscopy indicated a significantly higher number of
fluorine-labeled cells in the lysolecithin-damaged nerve than in the
contralateral control. Attempts to visualize macrophage responses
in EAE by 19F MRI in vivo failed so far, most likely due to insuf-
ficient sensitivity (reviewed in Stoll et al., 2012). Thus, despite its
superiority in specificity over SPIO/USPIO-based MRI, better coils
and more sensitive MRI sequences are needed for further in vivo
application of 19F MRI in the nervous system.
THE RELATION BETWEEN BREAKDOWN OF THE BBB/BNB
AND CELLULAR INFILTRATION
There is an ongoing debate whether leakage of the BBB for soluble
factors simultaneously provides an unrestricted access of inflam-
matory cells to the CNS. Histological data from chronic neurode-
generative diseases and EAE already challenged this notion by
showing that leukocytes infiltrated the perivascular space with-
out concomitant BBB leakage (Perry et al., 1997; Engelhardt and
Wolburg, 2004). Using serial section electron microscopy Wol-
burg et al. (2005) revealed that mononuclear cells traverse cerebral
microvessels by a transcellular pathway, leaving the endothelial
tight junctions intact. Moreover, diffusion of hydrophilic mole-
cules and leukocyte recruitment into the CNS take place at distinct
sites of the cerebral vascular tree. While the diffusion barrier for
solutes is formed by specialized endothelial cells at the level of cap-
illaries leukocyte extravasation usually occurs in the post-capillary
segments (Bechmann et al., 2007; Engelhardt and Sorokin, 2009).
The advent of novel MR imaging techniques contributed to
the partial solution of this controversy. In the first paragraphs
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we described contrast agents allowing assessment of BBB/BNB
dysfunction (Gd-DTPA, Gf M) as well as SPIO/USPIO enhanced
MRI to monitor macrophage infiltration. Combined use of these
MR contrast agents in individual animals and selected patients
disclosed that breakdown of the BBB/BNB and macrophage infil-
tration can occur independently: in other words inflammatory
cells can cross the BBB without acutely disturbing the BBB, and,
vice versa, long-lasting disruption of the BBB/BNB does not
necessarily entertain permanent cellular infiltration.
EAE AND MS
First MR evidence that migration of inflammatory cells to the
nervous system is not compulsorily associated with BBB/BNB
opening arose from experiments in EAE animals. Rausch et al.
(2003) described EAE lesions exhibiting either USPIO or Gd-
DTPA enhancement. This mismatch was most prominent during
the first relapse when large numbers of USPIO enhancing lesions
did not show any Gd-DTPA uptake. Floris et al. (2004) claimed that
impairment of the BBB (as shown by Gd-DTPA enhancement)
preceded monocyte infiltration (as assessed by USPIO enhance-
ment) in EAE thereby implicating a firm sequence of events in
lesion formation. This view was later on challenged by others
(Bendszus et al., 2005a; Berger et al., 2006). These studies described
USPIO/SPIO positive lesions in areas with an intact BBB sugges-
tive for a different pattern of lesion evolution. Interestingly, in the
latter study USPIO enhancing lesions disappeared after the acute
inflammatory attack,while areas with BBB damage recovered more
slowly (Berger et al., 2006).
As discussed above Gd-DTPA enhancement underestimates the
number of lesions with breakdown of the BBB. We therefore took
advantage of the more sensitive MR contrast agent Gf and com-
pared the number and location of Gf and SPIO enhancing lesions
in individual rats with EAE (Ladewig et al., 2009). Numerous Gf
positive lesions appeared in the spinal cord, brain stem, and optic
nerves and roughly a similar number of lesions showed signal
loss after SPIO application indicative for macrophage infiltration.
However, the spatial distribution of the lesions was completely
different with almost no overlap (Figures 2E,F). These findings
provide further evidence that macrophages can enter the CNS
leaving the BBB intact (SPIO positive, Gf negative lesions) and
that breakdown of the BBB (Gf positive lesions) is not necessarily
associated with cellular inflammation (SPIO positive lesions). At
present it is unclear how these processes interact, e.g., whether cel-
lular infiltration evokes BBB leakage with a delay or vice versa
transient disturbances of the BBB predetermine sites of later
cellular invasion in EAE.
Though Gf has not yet been developed for human application,
clinical studies in MS patients using Gd-DTPA strongly support
the results obtained in EAE animals. Dousset et al. (2006) per-
formed a Gd-DTPA/USPIO enhanced MRI study in a cohort
of 10 relapsing-remitting MS patients and found that 31 out of
57 lesions were collectively enhanced with both contrast agents.
Importantly, 24 Gd-DTPA enhancing lesions were USPIO negative
while two USPIO lesions did not show Gd-DTPA uptake. Vellinga
et al. (2008) compared USPIO enhanced MRI to the longitudi-
nal pattern of Gd-DTPA enhancement in 19 relapsing-remitting
MS patients. They found that 77% of USPIO positive lesions were
located in areas with an intact BBB. Moreover, USPIO enhancing
lesions were more abundant than Gd-DTPA enhancing lesions and
remained visible for longer time periods than Gd-DTPA. In 4% of
USPIO positive lesions USPIO enhancement preceded Gd-DTPA
uptake by several weeks. Just recently, Tourdias et al. (2012) lon-
gitudinally assessed disease activity with combined Gd-DTPA and
USPIO enhanced MRI in 10 relapsing patients and 14 patients
with progressive MS over a 6 month period. In this study, the
use of both contrast agents considerably increased the diagnostic
yield enabling the detection of 51% more lesions than with Gd-
DTPA alone. USPIO enhancement was also observed in patients
with a progressive disease course lacking Gd-DTPA enhancement
(Tourdias et al., 2012). Thus, these studies unanimously support
the assumption that SPIO/USPIO and Gd-DTPA enhanced MRI
cover different aspects of MS pathophysiology and activity.
ISCHEMIC STROKE
Several MRI studies conducted in experimental stroke also indi-
cate that BBB opening and cellular inflammation are not nec-
essarily linked. In the PT model it was shown that SPIO-laden
macrophages enter the lesion at a subacute stage (around day 6)
while BBB breakdown occurs immediately after lesion evolution
and persists for weeks (Kleinschnitz et al., 2003, 2005). Beyond
that, macrophages were still abundant in the infarction at later time
points but did not show any iron uptake (Kleinschnitz et al., 2003).
In MCAO models available data is more controversial. While some
studies failed to show iron-induced signal loss in the infarction
despite prolonged opening of the BBB and infiltration of neu-
trophils (Denes et al., 2007), others suggest that USPIO penetrate
in the CNS as free particles over a disrupted barrier (Deses-
tret et al., 2009). Thus, there is an ongoing controversy to what
extent USPIO enhancement corresponds to leukocyte infiltration
or passive leakage through a defective BBB.
Most importantly, diverse signatures of conventional Gd-DTPA
and iron-enhanced MRI persisted when the application of USPIO
was transferred to patients with ischemic stroke. Saleh et al. (2004)
found USPIO-related signal changes in the subacute infarct stage
of ten stroke patients, while Gd-DTPA enhancement occurred in
only six of them. In another study, Nighoghossian et al. (2007)
confirmed spatial discrepancies between USPIO-related signal
alterations and BBB breakdown assessed by Gd-DTPA in patients
with anterior circulation stroke.
NERVE TRAUMA
The conception that breakdown of barriers in the nervous system
is not necessarily congruent with cellular infiltration is further
reinforced by studies in nerve trauma. Axotomy or crush of a
peripheral nerve leads to degeneration of the distal nerve segment
(WD) accompanied by a rapid breakdown of the BNB as shown
by extravasation of albumin in histological studies (Seitz et al.,
1989; Bouldin et al., 1991). Accordingly, degenerating nerves show
continuous Gf enhancement throughout WD which terminates
not until successful regeneration is accomplished (Bendszus et al.,
2005b). Upon SPIO enhanced MRI a different picture emerges
(Bendszus and Stoll, 2003). SPIO-induced signal loss indicative
of macrophage infiltration starts at the lesion site within 2 days,
extends distally within the first week after injury and suddenly
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ceases after 10 days (Figure 4). Thus, SPIO application later than
10 days after nerve injury is not further accompanied by signal
alterations on T2-w MRI despite the fact that the BNB is still
defective. Functionally, these findings indicate that, despite per-
sistent breakdown of the BNB for up to 4 weeks after injury
(when nerve regeneration is completed), there is no continu-
ous macrophage invasion at the late phase of WD and regen-
eration. The pattern of macrophage invasion revealed by SPIO
enhanced MRI very well corresponded to the local expression
of chemokines in the degenerating nerve supporting the notion
that the local molecular environment, but not the simple break-
down of the BNB is responsible for the attraction of inflammatory
cells.
CONCLUSION
The ability to visualize nervous tissue by MRI has revolutionized
clinical neurology during the last three decades, but the signal
alterations seen in diseases are mainly non-specific. The use of
Gd-DTPA as a MR contrast agent allows detection of tumors and
areas with a disturbed BBB, however, sensitivity is limited. In an
attempt to depict molecular and cellular processes more precisely
novel contrast agents have been developed. In experimental stud-
ies, Gf allows more sensitive assessment of disturbances of the
BBB and BNB than Gd-DTPA. Thereby, the diagnostic yield is
highly increased in animal models of MS, functional and transient
changes of BBB properties hitherto undisclosed can be assessed
and, finally, the process of nerve regeneration which is linked
to sealing of the BNB, can be accurately followed. Cellular con-
trast agents such as iron-containing SPIO/USPIO or PFC allow
tracking of inflammatory responses by MRI, mainly macrophage
infiltration into the NS. By combining both imaging technolo-
gies it became increasingly clear that breakdown of the BBB/BNB
and leukocyte infiltration are distinct processes showing much less
overlap than previously anticipated. Further clinical development
of these MR contrast agents is warranted since they hold promise
to provide unique insights into the pathophysiology and dynamics
of inflammatory disorders of the NS and could improve treatment
surveillance.
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